Biotech · Private company
xCures
Track this companyFree. Adds xCures to your Dealase workspace and tells you when its record changes.
Clinical trials80 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- BalversaBladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- Observation of patients with known, suspected, or at risk for COVID-19 infectionCoronavirusClinicalTrials.gov · fetched Nov 12, 2026
- Ulixertinib (BVD-523)Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare DiseasesUNKNOWN · started Jun 10, 2024ClinicalTrials.gov NCT06539169 · fetched Nov 12, 2026
- xPedite: A Study to Expedite DIPG and DMG ResearchWITHDRAWN · started Nov 1, 2023ClinicalTrials.gov NCT06140719 · fetched Nov 12, 2026
- Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)COMPLETED · started Jul 15, 2022ClinicalTrials.gov NCT05461430 · fetched Nov 12, 2026
- Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving ErdafitinibTERMINATED · started Nov 21, 2021ClinicalTrials.gov NCT05052372 · fetched Nov 12, 2026
- Behavior, Environment And Treatments for Covid-19COMPLETED · started Mar 21, 2020ClinicalTrials.gov NCT04321811 · fetched Nov 12, 2026
- A Patient-Centric Platform Trial for Precision OncologyUNKNOWN · started Feb 7, 2019ClinicalTrials.gov NCT03793088 · fetched Nov 12, 2026
- Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesAVAILABLEClinicalTrials.gov NCT04566393 · fetched Nov 12, 2026
- Expanded Access to Gallium Maltolate (GaM)AVAILABLEClinicalTrials.gov NCT06404034 · fetched Nov 12, 2026